Tafluprost ethyl amide – 10 mg

Brand:
Cayman
CAS:
1185851-52-8
Storage:
-20
UN-No:
De Minimis - 1170 / 3

Tafluprost ethyl amide is derived from 17-phenyl trinor Prostaglandin F2α(17-phenyl trinor PGF2α). A number of 17-phenyl trinor PGF2α derivatives have been approved for the treatment of glaucoma.{8941,8322,8839,9311} Of these, the ones wherein the 13,14-double bond has been hydrogenated retain relatively good potency, but show a significantly reduced incidence of local irritant side effects.{9736} Alternatively, it was recently reported that analogs incorporating a 15-deoxy-15,15-difluoro modification also had a favorable ophthalmic activity profile.{11598} Tafluprost is a 2-series, 16-phenoxy analog of PGF2α with the 15,15-difluoro substitution. As a free acid, Tafluprost is a very potent FP receptor agonist (Ki = 0.4 nM).{11598} Ethyl amides of PGs tend to increase lipid solubility, to improve uptake into tissues and to further lower the effective concentration.  

 

Available on backorder

SKU: 9000843 - 10 mg Category:

Description

A more lipid soluble derivative of Tafluprost, a very potent FP receptor agonist (Ki = 0.4 nM)


Formal name: N-ethyl-9α,11α-dihydroxy-15,15-difluoro-16-phenoxy-17,18,19,20-tetranor-prosta-5Z,13E-dien-1-amide

Synonyms:  Dechloro Dehydroxy Difluoro Ethylcloprostenolamide

Molecular weight: 437.5

CAS: 1185851-52-8

Purity: ≥98%

Formulation: A solution in ethanol